相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chemical analysis of synthetic cannabinoids as designer drugs in herbal products
Nahoko Uchiyama et al.
FORENSIC SCIENCE INTERNATIONAL (2010)
Use of High-Resolution Accurate Mass Spectrometry to Detect Reported and Previously Unreported Cannabinomimetics in Herbal High Products
Simon Hudson et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2010)
Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry
Joerg Teske et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2010)
Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds
Sebastian Dresen et al.
JOURNAL OF MASS SPECTROMETRY (2010)
ESI-MS/MS library of 1,253 compounds for application in forensic and clinical toxicology
Sebastian Dresen et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2009)
Identification of a Cannabinoid Analog as a New Type of Designer Drug in a Herbal Product
Nahoko Uchiyama et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2009)
Spice: A never ending story?
Rainer Lindigkeit et al.
FORENSIC SCIENCE INTERNATIONAL (2009)
'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?
Volker Auwaerter et al.
JOURNAL OF MASS SPECTROMETRY (2009)
CB1 cannabinoid receptor ligands
GA Thakur et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
Structure-activity relationships for 1-alkyl-3-(l-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors:: steric and electronic effects of naphthoyl substituents.: New highly selective CB2 receptor agonists
JW Huffman et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes
JW Huffman et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS
BK Matuszewski et al.
ANALYTICAL CHEMISTRY (2003)
Therapeutic potential of cannabinoids in CNS disease
JL Croxford
CNS DRUGS (2003)
Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding
MM Aung et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
Natural and synthetic endocannabinoids and their structure-activity relationships
SL Palmer et al.
CURRENT PHARMACEUTICAL DESIGN (2000)
分享论文
